Deep Medicine Acquisition...

NASDAQ: DMAQ · Real-Time Price · USD
2.96
-5.43 (-64.72%)
At close: Jan 31, 2024, 10:00 PM

Deep Medicine Acquisition Balance Sheet Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Mar 31, 2023 Mar 31, 2022
Cash & Equivalents
10.88M 595.54K 877.1K
Short-Term Investments
n/a 9.16M 127.76M
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
1.57M n/a n/a
Receivables
1.4M n/a n/a
Inventory
2.35M n/a n/a
Other Current Assets
162.36K 20.41K 315.31K
Total Current Assets
14.79M 9.78M 128.95M
Property-Plant & Equipment
778.12K n/a n/a
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
2.35M n/a n/a
Total Assets
17.14M 9.78M 128.95M
Account Payables
2.82M n/a n/a
Deferred Revenue
3.11M n/a n/a
Short-Term Debt
10.27M 1.86M 500K
Other Current Liabilities
n/a 930.07K 36.71K
Total Current Liabilities
15.78M 2.8M 536.71K
Long-Term Debt
314.86K n/a n/a
Other Long-Term Liabilities
5.69M 4.43M 4.43M
Total Long-Term Liabilities
6.01M 4.43M 4.43M
Total Liabilities
21.78M 7.22M 4.96M
Total Debt
10.59M 1.86M 500K
Common Stock
2.78K 8.99M 127.77M
Retained Earnings
-21.16M -6.44M -3.78M
Comprehensive Income
n/a n/a n/a
Shareholders Equity
-4.64M 2.55M 123.99M
Total Investments
n/a 9.16M 127.76M